Craft

Acutus Medical

Stock Price

$0.1

2024-10-29

Market Capitalization

$4.6 M

2024-10-29

Revenue

$20.2 M

FY, 2024

Acutus Medical Summary

Company Summary

Overview
Acutus Medical is committed to pioneering a breakthrough technology to optimize the treatment strategies for complex cardiac arrhythmias by developing innovative, safe, efficacious, and cost-effective solutions for individuals suffering from these complex cardiac arrhythmias. Our mission is to develop and market a platform technology of safe, cost-effective and clinically advanced tools for the minimally invasive diagnosis (mapping) of complex arrhythmias (Atrial Fibrillation and Ventricular Tachycardia) that enable Physicians to optimize treatments and expand the ablation/therapeutic markets. In the pursuit of our mission, we will conduct all of our activities with the highest integrity and strive to become the world’s most valued company within the markets we serve to patients, customers, colleagues, investors, business partners, employees, and the communities in which we work and live. Located in San Diego, California, the company was founded in 2011 by a creative Theoretical Physicist, an Electrophysiologist and a San Diego entrepreneur around the concept of a new breakthrough technology in electrophysiology.
Type
Public
Status
Active
Founded
2011
HQ
Carlsbad, CA, US | view all locations
Website
http://acutusmedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Diane Flynn

    Diane Flynn, Vice President, Business Development

  • Shaden Marzouk
  • John Sheridan, Director and Chair of the Compensation Committee

    LocationsView all

    2 locations detected

    • Carlsbad, CA HQ

      United States

      2210 Faraday Ave #100

    • Zaventem, Vlaanderen

      Belgium

      25 Ikaroslaan

    Acutus Medical Financials

    Summary Financials

    Revenue (FY, 2024)
    $20.2M
    Gross profit (FY, 2024)
    $1.0M
    Net income (FY, 2024)
    ($9.5M)
    Cash (FY, 2024)
    $14.0M
    EBIT (FY, 2024)
    ($57.0K)
    Enterprise value
    $23.2M

    Footer menu